Qian Jiage, Wolfson Carrie, Kramer Briana, Creanga Andreea A
University of Pittsburgh School of Medicine, Pittsburgh, PA.
Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
Am J Obstet Gynecol. 2025 Apr;232(4):394.e1-394.e10. doi: 10.1016/j.ajog.2024.08.030. Epub 2024 Aug 26.
The rising trend in maternal mortality over the past 3 decades sets the United States apart from all other high-income countries. Multidisciplinary state and city Maternal Mortality Review Committees conduct comprehensive reviews of maternal deaths, including assessments of preventability and contributing factors.
Assess preventability of and contributing factors to maternal mortality in the U.S.
This study is a secondary analysis of cross-sectional, population-based data from the most recent, publicly available Maternal Mortality Review Committee data from 40 state and 2 cities in the U.S. Preventability were analyzed among all deaths during pregnancy or within 1 year postpartum from any cause (pregnancy-associated deaths) and deaths during pregnancy or within 1 year postpartum from causes related to pregnancy or its management, but not from accidental causes (pregnancy-related deaths). We also explored preventability by cause-of-death and contributing factors grouped as community, patient-family, provider, facility, and health system factors.
Of deaths that occurred after 2010, between 53% to 93.8% of pregnancy-associated deaths and 45% to 100% of pregnancy-related deaths were deemed preventable across the 42 states and cities. Across the 10 states reporting pregnancy-related death preventability by cause-of-death, Maternal Mortality Review Committees deemed preventable >90% of deaths from preeclampsia-eclampsia and mental health conditions, >80% of deaths from hemorrhage and cardiovascular conditions, about 70% of deaths from infection and thrombotic embolism, and about 40% of deaths from amniotic fluid embolism and stroke. A total of 3345 contributing factors were described in Maternal Mortality Review Committee reports from 14 states in relation to 739 pregnancy-related deaths. While collectively patient-family and provider factors were most frequently noted as contributing to pregnancy-related deaths, the contribution of such factors varied between 6% to 56% and 18% to 42.3%, respectively, across the states. Based on data from 20 Maternal Mortality Review Committees with available information, racism or discrimination were noted in relation to 37.7% of pregnancy-related deaths.
A large proportion of pregnancy-associated deaths and pregnancy-related deaths in the U.S. are preventable. However, likely due to differences in Maternal Mortality Review Committee membership, available data, and judgement employed to determine preventability, wide variation exists in the proportion of deaths deemed preventable and factors identified as contributing to such deaths across states. There is need to reevaluate the definitions, structure, and outputs for maternal death preventability assessments currently employed by a majority Maternal Mortality Review Committees to adequately inform state and national programming and policies.
在过去三十年里,孕产妇死亡率呈上升趋势,这使美国有别于所有其他高收入国家。多学科的州和市孕产妇死亡审查委员会对孕产妇死亡进行全面审查,包括对可预防性及促成因素的评估。
评估美国孕产妇死亡的可预防性及促成因素。
本研究是对来自美国40个州和2个城市的最新公开可用的孕产妇死亡审查委员会横断面人群数据的二次分析。对所有孕期或产后1年内因任何原因导致的死亡(与妊娠相关的死亡)以及孕期或产后1年内因与妊娠或其管理相关的原因而非意外原因导致的死亡(与妊娠相关的死亡)的可预防性进行了分析。我们还按死因以及分为社区、患者-家庭、提供者、机构和卫生系统因素的促成因素来探究可预防性。
在2010年之后发生的死亡中,在这42个州和城市中,53%至93.8%的与妊娠相关的死亡以及45%至100%的与妊娠相关的死亡被认为是可预防的。在报告了按死因划分的与妊娠相关死亡可预防性的10个州中,孕产妇死亡审查委员会认为,子痫前期-子痫和心理健康状况导致的死亡中超过90%是可预防的,出血和心血管疾病导致的死亡中超过80%是可预防的,感染和血栓栓塞导致的死亡中约70%是可预防的,羊水栓塞和中风导致的死亡中约40%是可预防的。14个州的孕产妇死亡审查委员会报告中总共描述了3345个与739例与妊娠相关死亡有关的促成因素。虽然总体而言患者-家庭和提供者因素最常被指出是导致与妊娠相关死亡的因素,但这些因素的贡献在各州之间分别在6%至56%和18%至42.3%之间有所不同。根据20个有可用信息的孕产妇死亡审查委员会的数据,在37.7%的与妊娠相关死亡中提到了种族主义或歧视。
美国很大一部分与妊娠相关的死亡和与妊娠相关的死亡是可预防的。然而,可能由于孕产妇死亡审查委员会成员、可用数据以及用于确定可预防性的判断存在差异,各州认为可预防的死亡比例以及确定为导致此类死亡的因素存在很大差异。有必要重新评估大多数孕产妇死亡审查委员会目前用于孕产妇死亡可预防性评估的定义、结构和结果,以便为州和国家的规划及政策提供充分信息。